RainPath
La Mézière
About RainPath
RainPath AI leverages advanced artificial intelligence to perform virtual staining of biopsy tissue slides, a cutting-edge technology that digitally replicates traditional chemical staining used in pathology without physically applying dyes. This process transforms unstained tissue images into highly detailed, colorized images that mimic conventional histological stains like hematoxylin and eosin (H&E), enabling pathologists to analyze tissue morphology rapidly and accurately.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $3.0M
- Funding stage: Seed
- Last round: Seed (Jul 2025)
- Website: rainpath.ai
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Health Care, Health Diagnostics, Hospital, Medical
Social Profiles
Canonical: https://fsome.com/organization/rainpath-9348 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.